Ohashi M - Search Results

1

Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.

Sugikawa E, Hosoi T, Yazaki N, Gamanuma M, Nakanishi N, Ohashi M. Sugikawa E, et al. Among authors: ohashi m. Anticancer Res. 1999 Jul-Aug;19(4B):3099-108. Anticancer Res. 1999. PMID: 10652599

2

9-Hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein.

Sugikawa E, Tsunoda S, Nakanishi N, Ohashi M. Sugikawa E, et al. Among authors: ohashi m. Anticancer Res. 2001 Jul-Aug;21(4A):2671-5. Anticancer Res. 2001. PMID: 11724337

3

Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.

Sugikawa E, Yazaki N, Tsunoda S, Nakanishi N, Ohashi M. Sugikawa E, et al. Among authors: ohashi m. Biochem Biophys Res Commun. 1999 Aug 2;261(2):256-63. doi: 10.1006/bbrc.1999.1019. Biochem Biophys Res Commun. 1999. PMID: 10425175

4

Calmodulin antagonistic action of new 1,5-benzothiazepines derived from diltiazem.

Suzuki T, Ohashi M, Takaiti O, Harigaya S. Suzuki T, et al. Among authors: ohashi m. Arzneimittelforschung. 1994 Jan;44(1):3-6. Arzneimittelforschung. 1994. PMID: 8135875

5

Disposition and metabolic fate of clentiazem in rats and dogs.

Nakamura S, Sugawara Y, Fukushima T, Ito Y, Ohashi M, Takaiti O. Nakamura S, et al. Among authors: ohashi m. Biol Pharm Bull. 1993 Jul;16(7):647-55. doi: 10.1248/bpb.16.647. Biol Pharm Bull. 1993. PMID: 8401396

6

Metabolism of clentiazem in rats.

Nakamura S, Sugawara Y, Fukushima T, Ito Y, Ohashi M, Takaiti O. Nakamura S, et al. Among authors: ohashi m. Biol Pharm Bull. 1993 Jul;16(7):635-46. doi: 10.1248/bpb.16.635. Biol Pharm Bull. 1993. PMID: 8401395

7

Metabolism of diltiazem. II. Metabolic profile in rat, dog and man.

Sugawara Y, Nakamura S, Usuki S, Ito Y, Suzuki T, Ohashi M, Harigaya S. Sugawara Y, et al. Among authors: ohashi m. J Pharmacobiodyn. 1988 Apr;11(4):224-33. doi: 10.1248/bpb1978.11.224. J Pharmacobiodyn. 1988. PMID: 3411440

8

Metabolism of diltiazem. I. Structures of new acidic and basic metabolites in rat, dog and man.

Sugawara Y, Ohashi M, Nakamura S, Usuki S, Suzuki T, Ito Y, Kume T, Harigaya S, Nakao A, Gaino M, et al. Sugawara Y, et al. Among authors: ohashi m. J Pharmacobiodyn. 1988 Apr;11(4):211-23. doi: 10.1248/bpb1978.11.211. J Pharmacobiodyn. 1988. PMID: 3411439

9

Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.

Nakamura S, Ohashi M, Suzuki T, Sugawara Y, Usuki S, Takaiti O. Nakamura S, et al. Among authors: ohashi m. Arzneimittelforschung. 1989 Sep;39(9):1100-8. Arzneimittelforschung. 1989. PMID: 2590259

10

Metabolism of diltiazem. III. Oxidative deamination of diltiazem in rat liver microsomes.

Nakamura S, Ito Y, Fukushima T, Sugawara Y, Ohashi M. Nakamura S, et al. Among authors: ohashi m. J Pharmacobiodyn. 1990 Oct;13(10):612-21. doi: 10.1248/bpb1978.13.612. J Pharmacobiodyn. 1990. PMID: 2095401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results